Azimuth Capital Investment Management LLC Astrazeneca PLC Transaction History

Azimuth Capital Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $96,126 - $104,238	-1,375 Reduced 2.11%	63,820 $4.57 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $93,777 - $106,325	-1,485 Reduced 2.23%	65,195 $4.53 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $84,296 - $109,534	-1,555 Reduced 2.28%	66,680 $4.52 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $144,744 - $370,597	-2,730 Reduced 3.85%	68,235 $3.74 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $4.21 Million - $5.05 Million	70,965 New	70,965 $4.69 Million

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Azimuth Capital Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Azimuth Capital Investment Management LLC with notifications on news.